(Q33951887)

30 July 2017

1 reference

title

Adventures in the pharmacological analysis of P2 receptors (English)

1 reference

30 July 2017

Fagura MS

1

1 reference

30 July 2017

Jarvis GE

series ordinal

2

1 reference

30 July 2017

Dougall IG

series ordinal

3

1 reference

30 July 2017

Leff P

series ordinal

4

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Journal of the autonomic nervous system

30 July 2017

published in

1 reference

30 July 2017

volume

81

1 reference

30 July 2017

issue

1-3

1 reference

30 July 2017

page(s)

178-186

1 reference

Pharmacological characterization of recombinant human and rat P2X receptor subtypes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Is there a basis for distinguishing two types of P2-purinoceptor?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Pharmacological profile of the novel P2T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Distribution of P2Y receptor subtypes on haematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Role of P2Y1 purinoceptor in ADP-induced platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900136-3

7 January 2021

10.1016/S0165-1838(00)00136-3

Identifiers

DOI

1 reference

30 July 2017

1 reference